The frequency of CD56dim CD16+ within the live PBMC is similar in EBV+ vs. EBV- cHL samples (data not shown), indicating that the effective E:T ratios applied for the 14 samples chosen for this assay are comparable between both groups. The gene discussed is FCGR3A; the disease is classic Hodgkin lymphoma.